Publication | Closed Access

A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist

Medicinal ChemistryBiochemistryFunctional SelectivityMedicineNatural SciencesReceptor AntagonistMechanism Of ActionPharmacological AgentReceptor (Biochemistry)PharmacotherapyVanilloid 1Propanal Oxime CompoundPharmacologyDrug Discovery